机器学习优化 natriuretic在急性心力衰竭的诊断中的使用
Dimitrios Doudesis1,2, Kuan Ken Lee1, Mohamed Anwar1
1British Heart Foundation (BHF) Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
European heart journal. Acute cardiovascular care
|April 12, 2025
概括
准则推的急性心力衰竭的B型尿素 (BNP) 和中区域前耳尿素 (MR-proANP) 值显示出可变的诊断性能. 一个新的决策支持工具,CoDE-HF,将尿素与临床数据相结合,为个人诊断提供了更高的准确性.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 诊断的准确性 诊断的准确性
背景情况:
- 建议用于诊断急性心力衰竭使用B型尿素 (BNP) 和中区域前性尿素 (MR-proANP).
- 根据当前的指导方针,这些生物标志物的诊断性能是不确定的,并且在不同患者群体中可能有所不同.
研究的目的:
- 系统地评估急性心力衰竭中BNP和MR-proANP的诊断性能.
- 开发和验证基于机器学习的决策支持工具 (CoDE-HF),以更准确地诊断急性心力衰竭.
主要方法:
- 进行了对14项研究的系统审查和个体患者级数据元分析,涉及8,493名BNP患者和3,899名MR-proANP患者.
- 开发并外部验证了CoDE-HF工具,将天然尿素水平与临床变量结合起来.
- 通过负和正预测值以及曲线下的面积等指标评估诊断性能.
主要成果:
- 准则值显示出不同的诊断性能,NPV为93.6%,MR-proANP为95.6%,PPV分别为68.8%和64.8%.
- CoDE-HF工具表现出优异的歧视 (AUC 0.914-0.929) 和校准,识别了具有高NPV (98.5%) 的低概率组和具有实质性PPV (75.1-78.6%) 的高概率组.
- CoDE-HF的表现在各个子组中是一致的,提供了更个性化的诊断方法.
结论:
- 对于急性心力衰竭的标准BNP和MR-proANP值的诊断性能在患者子组之间不一致.
- CoDE-HF决策支持工具,整合尿酸和临床数据,为诊断急性心力衰竭提供了更准确和个性化的方法.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
01:22Heart Failure Drugs: Diuretics
295
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
295
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
01:22Heart Failure Drugs: β-Blockers
278
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
278
01:26Heart Failure Drugs: Inotropic Agents
426
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
426
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K